Top

CardioVascular and Interventional Radiology

Published in:

01-07-2008 | Case Report

Treatment of Superior Vena Cava (SVC) Syndrome and Inferior Vena Cava (IVC) Thrombosis in a Patient with Colorectal Cancer: Combination of SVC Stenting and IVC Filter Placement to Palliate Symptoms and Pave the Way for Port Implantation

Authors: Alexander Sauter, Jürgen Triller, Felix Schmidt, Ralph Kickuth

Published in: CardioVascular and Interventional Radiology | Special Issue 2/2008

Abstract

Thrombosis of the inferior vena cava is a life-threatening complication in cancer patients leading to pulmonary embolism. These patients can also be affected by superior vena cava syndrome causing dyspnea followed by trunk or extremity swelling. We report the case of a 61-year-old female suffering from an extended colorectal tumor who became affected by both of the mentioned complications. Due to thrombus formation within the right vena jugularis interna, thrombosis of the inferior vena cava, and superior vena cava syndrome, a combined interventional procedure via a left jugular access with stenting of the superior vena cava and filter placement into the inferior vena cava was performed As a consequence, relief of the patient’s symptoms, prevention of pulmonary embolism, and paving of the way for further venous chemotherapy were achieved.

American Cancer Society (2006) Cancer facts and figures 2006. American Cancer Society, Atlanta, GA

Jaffer AK (2005) Issues in anticoagulant therapy: recent trials start to answer the tough questions. Cleve Clin J Med 72:157–163PubMedCrossRef

Otten HM, Mathijssen J, ten Cate H, Soesan M, Inghels M, Richel DJ, Prins MH (2004) Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med 164:190–194PubMedCrossRef

Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846–1850PubMedCrossRef

Schafer AI, Levine MN, Konkle BA, Kearon C (2003) Thrombotic disorders: diagnosis and treatment. Hematol Am Soc Hematol Educ Program 1:520–539

Van Gerpen R, Mast ME (2004) Thromboembolic disorders in cancer. Clin J Oncol Nurs 8:289–299PubMedCrossRef

Kim SH, Brennan MF, Russo P, Burt ME, Coit DG (1998) The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer 82:389–394PubMedCrossRef

Lee JJ, Kupfer J, Raissi S, Geller SA, Siegel RJ (1998) Rapid extension of left adrenocortical carcinoma into the right atrium. J Am Soc Echocardiogr 11:86–88PubMedCrossRef

Zisman A, Wieder JA, Pantuck AJ, Chao DH, Dorey F, Said JW, Gitlitz BJ, deKernion JB, Figlin RA, Belldegrun AS (2003) Renal cell carcinoma with tumor thrombus extension: biology, role of nephrectomy and response to immunotherapy. J Urol 169:909–916PubMedCrossRef

10.

Lanciego C, Chacon JL, Julian A, Andrade J, Lopez L, Martinez B, Cruz M, Garcia-Garcia L (2001) Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR 177:585–593PubMed

11.

Marcy PY, Magne N, Bentolila F, Drouillard J, Bruneton JN, Descamps B (2001) Superior vena cava obstruction: Is stenting necessary? Support Care Cancer 9:103–107PubMedCrossRef

12.

Trousseau A (1865) Phlegmasia alba dolens. In: Trousseau A (ed) Clinique medicale de l’Hotel-Dieu de Paris, Vol. 3. Balliere, Paris, pp 654–712

13.

Saphner T, Tormey DC, Gray R (1991) Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9:286–294PubMed

14.

Viale PH, Schwartz RN (2004) Venous thromboembolism in patients with cancer. Part II. Current treatment strategies. Clin J Oncol Nurs 8:465–469PubMedCrossRef

15.

Cunningham RS (2005) Therapeutic options for the treatment of cancer-associated thrombosis. Semin Oncol Nurs 21(Suppl 1):21–40PubMedCrossRef

16.

Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 62:14–31PubMed

17.

Levitan N., Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, Rimm AA (1999) Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore) 78:285–291CrossRef

18.

Kuzel T, Esparaz B, Green D, Kies M (1990) Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 65:885–889PubMedCrossRef

19.

Feffer SE, Carmosino LS, Fox RL (1989) Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil. Cancer 63:1303–1307PubMedCrossRef

20.

Bertomeu MC, Gallo S, Lauri D, Levine MN, Orr FW, Buchanan MR (1990) Chemotherapy enhances endothelial cell reactivity to platelets. Clin Exp Metastasis 8:511–518PubMedCrossRef

21.

Rodrigues CI, Njo KH, Karim AB (1993) Hypofractionated radiation therapy in the treatment of superior vena cava syndrome. Lung Cancer 10:221–228PubMedCrossRef

22.

Charnsangavej C, Carrasco CH, Wallace S, Wright KC, Ogawa K, Richli W, Gianturco C (1986) Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stents. Radiology 161:295–298PubMed

23.

Uberoi R (2006) Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Interv Radiol 29:319–322CrossRef

24.

Wallace MJ, Jean JL, Gupta S, Eapen GA, Johnson MM, Ahrar K, Madoff DC, Morello FA, Murthy R, Hicks ME (2004) Use of inferior vena caval filters and survival in patients with malignancy. Cancer 101:1902–1907PubMedCrossRef

25.

Jarrett BP, Dougherty MJ, Calligaro KD (2002) Inferior vena cava filters in malignant disease. J Vasc Surg 36:704–707PubMed

26.

Henkle G, Kunz P, Funaki B (2004) Patterns of referral for inferior vena caval filtration: delays and their impact. AJR 183:1021–1024PubMed

27.

Decousus H, Leizorovicz A, Parent F, et al. (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with deep venous thrombosis prevention du risque d’embolie pulmonaire par interruption. Cave Study Group. N Engl J Med 338:409–415PubMedCrossRef

28.

Hann CL, Streiff MB (2005) The role of vena caval filters in the management of venous thromboembolism. Blood Rev 19:179–202PubMedCrossRef

Title: Treatment of Superior Vena Cava (SVC) Syndrome and Inferior Vena Cava (IVC) Thrombosis in a Patient with Colorectal Cancer: Combination of SVC Stenting and IVC Filter Placement to Palliate Symptoms and Pave the Way for Port Implantation
Authors: Alexander Sauter
Jürgen Triller
Felix Schmidt
Ralph Kickuth
Publication date: 01-07-2008
Publisher: Springer-Verlag
Published in: CardioVascular and Interventional Radiology / Issue Special Issue 2/2008
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-007-9113-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Treatment of Superior Vena Cava (SVC) Syndrome and Inferior Vena Cava (IVC) Thrombosis in a Patient with Colorectal Cancer: Combination of SVC Stenting and IVC Filter Placement to Palliate Symptoms and Pave the Way for Port Implantation

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Special Issue 2/2008

Unusual Presentation of Infected Vertebroplasty with Delayed Cement Dislodgment in an Immunocompromised Patient: Case Report and Review of Literature

Endovascular Treatment of AVF after Hair Transplantation

Percutaneous Radiofrequency Ablation for Treatment of Recurrent Retroperitoneal Liposarcoma

Stenting in Acute Lower Limb Arterial Occlusions

Chronic Contained Rupture of an Abdominal Aortic Aneurysm: From Diagnosis to Endovascular Resolution

Systemic Artery to Pulmonary Artery Fistula Associated with Mitral Regurgitation: Successful Treatment with Endovascular Embolization